Repurposed drug enters fight against Parkinson's symptoms
NCT ID NCT05931575
Summary
This study is testing a drug called fasudil to see if it is safe and can help ease symptoms in people with early Parkinson's disease. Seventy-five participants will take the drug or a placebo pill twice a day for three weeks. Researchers will measure changes in movement, daily function, and quality of life to see if the treatment provides relief.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PARKINSON´S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Technische Universität München, Klinikum rechts der Isar, Klinik und Poliklinik für Neurologie
RECRUITINGMunich, 81675, Germany
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.